Cargando…
Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors
Chromobox protein homolog 3 (CBX3) has been recognized as a member of the heterochromatin protein 1 family and participate in transcriptional activation or inhibition, cell differentiation and growth. Despite more and more evidence shows that CBX3 has a critical function in the development of some t...
Autores principales: | Xu, Haitao, Jiang, Caihong, Chen, Dangui, Wu, Youzhi, Lu, Jia, Zhong, Long, Yao, Fusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096250/ https://www.ncbi.nlm.nih.gov/pubmed/35573019 http://dx.doi.org/10.3389/fmed.2022.869994 |
Ejemplares similares
-
Pan-Cancer Analysis Reveals the Relation between TRMT112 and Tumor Microenvironment
por: Xu, Haitao, et al.
Publicado: (2022) -
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
por: Niu, Hongjuan, et al.
Publicado: (2022) -
Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer
por: Li, Xinxin, et al.
Publicado: (2023) -
Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022) -
CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma
por: Yang, Yanlong, et al.
Publicado: (2021)